nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.279	0.342	CbGaD
Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.241	0.295	CbGaD
Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.167	0.204	CbGaD
Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.129	0.158	CbGaD
Methotrimeprazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00262	0.0603	CbGeAlD
Methotrimeprazine—DRD4—brain—Gilles de la Tourette syndrome	0.00129	0.0297	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00128	0.0294	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00123	0.0283	CbGeAlD
Methotrimeprazine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00119	0.0273	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0263	CbGeAlD
Methotrimeprazine—DRD5—nervous system—Gilles de la Tourette syndrome	0.00111	0.0256	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00107	0.0247	CbGeAlD
Methotrimeprazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00103	0.0238	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000998	0.023	CbGeAlD
Methotrimeprazine—CHRM4—brain—Gilles de la Tourette syndrome	0.000976	0.0225	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000961	0.0221	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000912	0.021	CbGeAlD
Methotrimeprazine—DRD3—brain—Gilles de la Tourette syndrome	0.000907	0.0209	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.000892	0.0205	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000878	0.0202	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.000859	0.0198	CbGeAlD
Methotrimeprazine—DRD5—brain—Gilles de la Tourette syndrome	0.00085	0.0196	CbGeAlD
Methotrimeprazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00085	0.0196	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000818	0.0188	CbGeAlD
Methotrimeprazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000803	0.0185	CbGeAlD
Methotrimeprazine—CHRM5—brain—Gilles de la Tourette syndrome	0.000763	0.0176	CbGeAlD
Methotrimeprazine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000697	0.016	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000685	0.0158	CbGeAlD
Methotrimeprazine—ADRA1D—brain—Gilles de la Tourette syndrome	0.000682	0.0157	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00066	0.0152	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000659	0.0152	CbGeAlD
Methotrimeprazine—DRD1—brain—Gilles de la Tourette syndrome	0.00065	0.015	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000636	0.0146	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000624	0.0144	CbGeAlD
Methotrimeprazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000611	0.0141	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.0006	0.0138	CbGeAlD
Methotrimeprazine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000594	0.0137	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000558	0.0128	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000537	0.0124	CbGeAlD
Methotrimeprazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000524	0.0121	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000512	0.0118	CbGeAlD
Methotrimeprazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000505	0.0116	CbGeAlD
Methotrimeprazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000502	0.0116	CbGeAlD
Methotrimeprazine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000493	0.0114	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000488	0.0112	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000483	0.0111	CbGeAlD
Methotrimeprazine—CHRM1—brain—Gilles de la Tourette syndrome	0.000477	0.011	CbGeAlD
Methotrimeprazine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000474	0.0109	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00047	0.0108	CbGeAlD
Methotrimeprazine—CHRM3—brain—Gilles de la Tourette syndrome	0.000426	0.00982	CbGeAlD
Methotrimeprazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000403	0.00927	CbGeAlD
Methotrimeprazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000397	0.00913	CbGeAlD
Methotrimeprazine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000392	0.00901	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00039	0.00897	CbGeAlD
Methotrimeprazine—DRD2—brain—Gilles de la Tourette syndrome	0.000384	0.00884	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000382	0.00879	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000381	0.00877	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000375	0.00863	CbGeAlD
Methotrimeprazine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000373	0.00859	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000367	0.00845	CbGeAlD
Methotrimeprazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000331	0.00762	CbGeAlD
Methotrimeprazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000326	0.0487	CrCbGaD
Methotrimeprazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000319	0.00734	CbGeAlD
Methotrimeprazine—HRH1—brain—Gilles de la Tourette syndrome	0.000303	0.00698	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000302	0.00695	CbGeAlD
Methotrimeprazine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000298	0.00685	CbGeAlD
Methotrimeprazine—CYP2E1—brain—Gilles de la Tourette syndrome	0.000291	0.00671	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00029	0.00669	CbGeAlD
Methotrimeprazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000254	0.0379	CrCbGaD
Methotrimeprazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000253	0.00583	CbGeAlD
Methotrimeprazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000248	0.037	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000246	0.0367	CrCbGaD
Methotrimeprazine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000231	0.00531	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000223	0.0332	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000222	0.0332	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000203	0.0302	CrCbGaD
Methotrimeprazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.0002	0.0298	CrCbGaD
Methotrimeprazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000185	0.0276	CrCbGaD
Methotrimeprazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000184	0.0274	CrCbGaD
Methotrimeprazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000181	0.027	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000178	0.0266	CrCbGaD
Methotrimeprazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000176	0.0262	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000174	0.026	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.00017	0.0254	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000162	0.0241	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000154	0.0229	CrCbGaD
Methotrimeprazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000148	0.0221	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000143	0.0213	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.00014	0.0209	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.00014	0.0209	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.00014	0.0208	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000138	0.0205	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000136	0.0203	CrCbGaD
Methotrimeprazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000133	0.0198	CrCbGaD
Methotrimeprazine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.00013	0.0193	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000129	0.0193	CrCbGaD
Methotrimeprazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000125	0.0186	CrCbGaD
Methotrimeprazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000123	0.0183	CrCbGaD
Methotrimeprazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000122	0.0181	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000119	0.0177	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0171	CrCbGaD
Methotrimeprazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.00011	0.0164	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000109	0.0162	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000108	0.0161	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0153	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.0001	0.0149	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	9.66e-05	0.0144	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	9.64e-05	0.0144	CrCbGaD
Methotrimeprazine—Imipramine—DRD2—Gilles de la Tourette syndrome	9.61e-05	0.0143	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	9.51e-05	0.0142	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	9.41e-05	0.014	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—Gilles de la Tourette syndrome	8.48e-05	0.0126	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	7.46e-05	0.0111	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	7.42e-05	0.0111	CrCbGaD
Methotrimeprazine—DRD5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000359	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.77e-05	0.000356	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.76e-05	0.000355	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.68e-05	0.00035	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.65e-05	0.000347	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.62e-05	0.000345	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.61e-05	0.000344	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.6e-05	0.000343	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.58e-05	0.000342	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.57e-05	0.000341	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.54e-05	0.000339	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.52e-05	0.000338	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000337	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.51e-05	0.000337	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.46e-05	0.000333	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.36e-05	0.000325	CbGpPWpGaD
Methotrimeprazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.32e-05	0.000322	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.32e-05	0.000322	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.3e-05	0.000321	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.3e-05	0.000321	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.26e-05	0.000318	CbGpPWpGaD
Methotrimeprazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.24e-05	0.000317	CbGpPWpGaD
Methotrimeprazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.23e-05	0.000316	CbGpPWpGaD
Methotrimeprazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.21e-05	0.000315	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.000314	CbGpPWpGaD
Methotrimeprazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.17e-05	0.000311	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.16e-05	0.000311	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.14e-05	0.000309	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	4.09e-05	0.000305	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.08e-05	0.000304	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.96e-05	0.000296	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.92e-05	0.000293	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.9e-05	0.000291	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.89e-05	0.00029	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.00029	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.87e-05	0.000289	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.87e-05	0.000289	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.85e-05	0.000288	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.84e-05	0.000286	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.77e-05	0.000282	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.76e-05	0.00028	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.73e-05	0.000278	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.72e-05	0.000278	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.72e-05	0.000278	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.71e-05	0.000277	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.7e-05	0.000276	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.69e-05	0.000275	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.62e-05	0.000271	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.6e-05	0.000268	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.57e-05	0.000266	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.55e-05	0.000265	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.53e-05	0.000263	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.52e-05	0.000262	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.5e-05	0.000261	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.48e-05	0.00026	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.47e-05	0.000259	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.47e-05	0.000259	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.46e-05	0.000258	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000256	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.38e-05	0.000252	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.38e-05	0.000252	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000251	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.36e-05	0.000251	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.35e-05	0.00025	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.33e-05	0.000248	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.29e-05	0.000246	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.23e-05	0.000241	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.23e-05	0.000241	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.23e-05	0.000241	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.22e-05	0.00024	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.21e-05	0.00024	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.19e-05	0.000238	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.18e-05	0.000238	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.18e-05	0.000237	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.17e-05	0.000237	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.15e-05	0.000235	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.15e-05	0.000235	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.14e-05	0.000235	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.14e-05	0.000234	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.14e-05	0.000234	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000234	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.09e-05	0.000231	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.05e-05	0.000228	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.05e-05	0.000227	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.02e-05	0.000225	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.01e-05	0.000224	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.00022	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.94e-05	0.000219	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.93e-05	0.000219	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.93e-05	0.000219	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.92e-05	0.000218	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.9e-05	0.000217	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.89e-05	0.000216	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.89e-05	0.000216	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.000215	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.88e-05	0.000215	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000214	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.86e-05	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000213	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000213	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.84e-05	0.000212	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.84e-05	0.000212	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.84e-05	0.000212	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000211	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.81e-05	0.000209	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000209	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000209	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000208	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.78e-05	0.000207	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000205	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.74e-05	0.000205	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.73e-05	0.000204	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.73e-05	0.000204	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.7e-05	0.000201	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.66e-05	0.000199	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.66e-05	0.000198	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.63e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.62e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.62e-05	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000195	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000195	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.61e-05	0.000195	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000194	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.6e-05	0.000194	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.000194	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.59e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000192	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000192	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.55e-05	0.00019	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.55e-05	0.00019	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.54e-05	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.53e-05	0.000189	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.52e-05	0.000188	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.5e-05	0.000187	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.49e-05	0.000186	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000185	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.46e-05	0.000184	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.46e-05	0.000184	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.000183	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.43e-05	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.43e-05	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.39e-05	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.38e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.37e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.37e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000176	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.35e-05	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.35e-05	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.33e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.32e-05	0.000173	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.32e-05	0.000173	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.32e-05	0.000173	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.28e-05	0.000171	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.22e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.21e-05	0.000165	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.21e-05	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.19e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.16e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.12e-05	0.000159	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000157	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.09e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.07e-05	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.06e-05	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2e-05	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2e-05	0.000149	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.98e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.86e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.86e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.81e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.8e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.78e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.73e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.73e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.71e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.68e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.66e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.61e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.57e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.57e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.55e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.55e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.54e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.54e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.54e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.53e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.52e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.52e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.49e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.48e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.47e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.47e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.45e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.41e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.4e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.4e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.39e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.39e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.39e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.38e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.37e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.37e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.32e-05	9.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.3e-05	9.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.3e-05	9.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.27e-05	9.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.18e-05	8.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.13e-05	8.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.1e-05	8.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.08e-05	8.07e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.97e-06	7.44e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.79e-06	7.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.76e-06	7.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.73e-06	7.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.63e-06	7.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.61e-06	7.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.93e-06	6.66e-05	CbGpPWpGaD
